NDC product
Fludeoxyglucose F18
NDC 13267-234 · THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Key facts
| Product NDC | 13267-234 |
|---|---|
| Proprietary name | Fludeoxyglucose |
| Nonproprietary name | Fludeoxyglucose F18 |
| Substances | FLUDEOXYGLUCOSE F-18 |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA021870 |
| Pharmacologic classes | Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA] |
| Marketing start | Aug 19, 2005 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: